Dear All, I am looking for academic research institutions and translational research centers interested in using modular physiologic culture media mimicking the chemical composition of human plasma. The composition of our physiologic media is chemically defined, but the media are made up of building blocks rather than single mixtures containing all the ingredients. The building modules separately contain energy (C-)sources, amino acids, non-proteinogenic amino acids, vitamins, phospholipid precursors, inorganic trace elements, bulk ions, intermediary metabolites and other key components of in vitro nutrition. The separation of metabolically related reagents makes it possible to design and even optimise physiological culture environments for different human cells types. This enables the use of chemically defined, physiological culture media in various fields of application, such as Organ-on-Chip, 3D-cultures, personalised cell therapy and regenerative medicine. Any comment, request of information or discussion is welcome. Best regards, Ferruccio Messi, PhD President & Founder, Cell Culture Technologies LLC www.cellculture.com
Info
Cell Culture Technologies is a private Swiss biotech company founded in 1992 by Ferruccio Messi, Ph.D. Proprietary technology includes (I) know-how with respect to cultivation and cryopreservation of human and animal cell lines in minimal culture environments, (II) know-how with respect to bioprocess development with cells cultivated in chemically defined, protein- and peptide-free minimal culture media, and (III) know-how regarding development and manufacturing of fully synthetic cell culture media. Cell Culture Technologies offers technology transfer programs to generate recombinant glycoproteins, monoclonal antibodies, viral particles and cells in fully synthetic culture environments. The European Collection of Cell Cultures (ECACC) has been distributing several serum-free adapted mammalian cell lines banked in minimal media developed and manufactured by Cell Culture Technologies since 2003. Furthermore, a number of biopharma companies developed product pipelines by cultivating CHO cells and hybridomas in Cell Culture Technologies’ minimal media. As shown by ChoMaster®EPO, our proprietary CHO cell line is considered one of the most promising host cell lines for the development of next-generation bioprocesses, including manufacturing of biosimilars. Last but not least, recent experimental evidence emphasizes the efficacy of our chemically defined culture media for human stem cells and stem cell lines. The company has boosted its proprietary technology since its founding and has entered into long-standing cooperation agreements with several biopharma companies, vaccine manufacturers and translational research centers, ranging from start-up to worldwide leading companies. To date, more than a hundred leading academic institutions and companies have selected Cell Culture Technologies as the partner of choice for the development and the application of highly specific cell culture media and methods.
- Website
-
www.cellculture.com
Externer Link zu Cell Culture Technologies
- Branche
- Biotechnologie
- Größe
- 2–10 Beschäftigte
- Hauptsitz
- Gravesano, Ticino
- Art
- Privatunternehmen
- Gegründet
- 1992
Orte
-
Primär
Wegbeschreibung
Via al Chioso 12
Gravesano, Ticino 6929, CH